Allison Dorval Puma Biotechnology, Inc. (PBYI) insider trading activity

Allison Dorval is Director of PUMA BIOTECHNOLOGY, INC.. Currently has a direct ownership of 75,390 shares of PBYI, which is worth approximately $253,310. The most recent transaction as insider was on Jun 13, 2025, when has been sold 11,610 shares (Common Stock) at a price of $3.4 per share, resulting in proceeds of $39,474. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 75.4K

25.65% 3M change

25.65% 12M change

Total Value Held $253,310

Allison Dorval Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 13 2025	SELL Open market or private sale	$39,474 $3.4 p/Share	11,610 Reduced 13.34%	75,390 Common Stock
Jun 11 2025	BUY Grant, award, or other acquisition	-	27,000 Added 23.68%	87,000 Common Stock
Jun 18 2024	BUY Grant, award, or other acquisition	-	27,000 Added 31.03%	60,000 Common Stock
Jun 13 2024	SELL Open market or private sale	$37,070 $3.37 p/Share	11,000 Reduced 25.0%	33,000 Common Stock
Jun 13 2023	SELL Open market or private sale	$34,500 $3.45 p/Share	10,000 Reduced 37.04%	17,000 Common Stock
Jun 13 2023	BUY Grant, award, or other acquisition	-	27,000 Added 38.03%	44,000 Common Stock
Jun 14 2022	BUY Grant, award, or other acquisition	-	27,000 Added 50.0%	27,000 Common Stock

Also insider at

VYGR

Voyager Therapeutics, Inc. Healthcare

Chief Financial Officer

AVTE

Aerovate Therapeutics, Inc. Healthcare

VERV

Verve Therapeutics, Inc. Healthcare

Chief Financial Officer

Allison Dorval

Director

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PBYI shares.

Notify only if

Value

Insider Trading

Get notified when an Puma Biotechnology, Inc. insider buys or sells PBYI shares.

Notify only if

Operation

Value

Type

News

Receive news related to PUMA BIOTECHNOLOGY, INC.

Track Activities on PBYI

Account